Detroit, MI – According to filings with the U.S. Securities and Exchange Commission, Functional Fluidics is raising $2,500,000.00 in new funding. Sources indicate as part of senior management Chief Operating Officer, John Cunningham played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Functional Fluidics

Functional Fluidics is a certified CLIA laboratory. We can receive clinical samples from our physician partners and provide results for patient monitoring as a clinical support tool. Our goal is set the standard for blood function diagnostics in Sickle Cell Disease and a wide range of bleeding and clotting disorders. No other company has more experience performing blood function assays to evaluate  therapies in Sickle Cell Disease than Functional Fluidics.

To learn more about Functional Fluidics, visit http://www.functionalfluidics.com/

Contact:
John Cunningham, Chief Operating Officer
313-482-9435
john@functionalfluidics.com
https://www.linkedin.com/in/johnwcunningham/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved